GIVE MISS CALL ON :- +91 99774 99927

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 21 MAY 2019

13960005 (2)

Morning news and update

Over the weekend, i.e. on Sunday, all traders had their eyes glued to their television sets to see what the exit polls have to say about the general elections. With all polls indicating the return of Modi-led NDA to power, the Nifty opened the session with a huge gap-up and, as the day progressed, the upmove got stronger and reached fresh lifetime high on a closing basis. Over the last four trading sessions, Nifty has gained over 720 points and has managed to close above all crucial short term and medium term moving average. Going ahead, the all-time high level of 11,856 will be closely monitored by the traders as sustaining above this level would further strengthen the bulls and the gates for the level of 12,000 would open up. On the downside, the level of 11,750 would be a crucial support for the Nifty.

PC Jeweller: The company is opening its new showroom at Sirsa (Haryana) on May 25, 2019.

ICICI Bank: The bank has entered into an agreement with BSE Limited to acquire 9.9 per cent stake in India International Exchange (INX) for a consideration of up to Rs 305 million in tranches.

GAIL: GAIL has contributed Rs 5 crore for relief work in cyclone-hit Odisha. Also, the meeting of the board of directors of the company is scheduled to be held on May 27 to consider the proposal for issuance of bonus shares.

Adani Green Energy: Adani Tradeline LLP and Universal Trade and Investments Ltd will sell up to 5.59 per cent stake via OFS at floor price at Rs 43 per share.

Dynamic Cables: The company has bagged two orders worth Rs 32 crore from one of the largest domestic EPC company of India for the manufacture and supply of HV and LV cables in the next nine-month period.

Panacea Biotec: Panacea Biotec’s oncology parenteral formulation facility at Baddi, Himachal Pradesh, has received United States Food & Drug Administration (USFDA) approval for the manufacture and supply of Azacitidine injection, 100 mg/vial, for the US market.

Indostar Capital Finance: The board of directors approved the issue of NCDs for an amount not exceeding Rs 10,000 crore.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Leave a Reply

Checking...

Ouch! There was a server error.
Retry »

Sending message...

FREE TRIAL REQUEST


CapitalStars FORUM